02 May 2022 | Geneva: A rapid communication released by the World Health Organization (WHO) Global Tuberculosis Programme has announced upcoming updates to the guidance on the treatment of drug-resistant tuberculosis (DR-TB). These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
All treatment should be delivered under WHO-recommended standards, including patient-centred care and support, informed consent where necessary, principles of good clinical practice, active drug safety monitoring and management, and regular monitoring of patients and of drug resistance to assess regimen effectiveness.
“We now have more and much better treatment options for people with drug-resistant TB thanks to research generating new evidence. This is major progress compared to what was available even a few years ago, and will be of great benefit for people struggling with TB and drug-resistant TB, resulting in better outcomes, saving lives and reducing suffering.”, said Dr Tereza Kasaeva, Director of WHO’s Global TB Programme. “We now need all hands on deck to enable the rapid uptake of these guidelines, and to enable access to the new treatment options for those in need.”
The Rapid Communication is released in advance of updated WHO consolidated guidelines expected later in 2022, to inform national TB programmes and other stakeholders of key changes in the treatment of DR-TB and to allow for rapid transition and planning at the country level.
Recommended readings
- National Strategic Plan to End Tuberculosis in Nepal
- Global Tuberculosis Report 2021
- Global Tuberculosis Report 2020
- World Tuberculosis Day
- Tuberculosis Free Nepal Declaration Initiative Implementation Guideline
- National Tuberculosis Program Update in Nepal #WorldTBDay #EndTB
- National TB Prevalence Survey, 2018-19 Key findings
- World Tuberculosis Day 2020! It’s time to End TB!
- National Guideline on Drug Resistant TB Management 2019, Nepal
- National Tuberculosis Management Guideline 2019, Nepal
- Global Tuberculosis Report 2019: Latest status of the tuberculosis epidemic
- National TB Prevalence Survey, 2018-19 Key findings
- New WHO recommendations to prevent tuberculosis aim to save millions of lives
- World Health Organization (WHO) Information Note Tuberculosis and COVID-19
- World Tuberculosis Day 2020! It’s time to End TB!
- People-centred framework for tuberculosis programme planning and prioritization, User guide
- Global Tuberculosis Report 2019: Latest status of the tuberculosis epidemic
- Dissemination of Findings and Recommendations of Joint External Monitoring Mission(JEMM) of Nepal National Tuberculosis Program
- National Tuberculosis Programme Annual Report 2018
- National Strategic Plan for Tuberculosis Prevention, Care and Control 2016 – 2021
- NTP, Nepal: New TB Treatment Algorithm & Regimen (Updated)
- WHO announces landmark changes in MDR-TB treatment regimens
- TB Vaccine results announce a promising step towards ending the emergency
- 7 million people receive record levels of lifesaving TB treatment but 3 million still miss out
Similar days
- World Tuberculosis Day 2021: The Clock Is Ticking
- World Tuberculosis Day 2020! It’s time to End TB!
- World Tuberculosis Day Observed with theme “It’s Time”
- World Tuberculosis Day 2019 – It’s time ! ”Find Treat All #EndTB”
- Important Message – World Tuberculosis Day 2018
- World Tuberculosis Day – 24 March 2015
- World Tuberculosis Day 2012 – ‘Stopping TB in My Lifetime’
- Theme for World TB Day 2074- National Tuberculosis Centre
